Objectives: A quick Pediatric Logistic Organ Dysfunction 2 score on day 1, consisting of tachycardia, hypotension, and altered mentation, was shown to predict mortality with an area under the receiver operating characteristic curve of 82% (95% CI, 76–87%) in children admitted to a PICU with suspected infection. We performed an external validation of the quick Pediatric Logistic Organ Dysfunction 2, including its performance in predicting mortality in specific age groups. Design: Analysis of retrospective data obtained from the Virtual Pediatric Systems PICU registry. Setting: Prospectively collected clinical records from 130 participating PICUs in North America. Patients: Children admitted between January 2009 and December 2014, with a diagnosis of infection at discharge, for whom all required data were available. Interventions: None. Measurements and Main Results: Systolic blood pressures, heart rates, and Glasgow Coma Scale scores were used to evaluate the quick Pediatric Logistic Organ Dysfunction 2 using area under the receiver operating characteristic curve analysis. Performance was compared with Pediatric Risk of Mortality 3 and Pediatric Index of Mortality 2 risk scores. Data from 42,196 children with complete data were analyzed, with median age 2.7 years (interquartile range, 0.7–8.8 yr; range 0–18 yr) and a 4.27% mortality rate. Mortality was 13.4% for quick Pediatric Logistic Organ Dysfunction 2 greater than or equal to 2 and 2.5% for quick Pediatric Logistic Organ Dysfunction 2 less than 2, representing a false-negative rate of 49.5%. Also 311 children (17%) who died had a quick Pediatric Logistic Organ Dysfunction 2 score of 0. The area under the receiver operating characteristic curve was 72.6% (95% CI, 71.4–73.8%) for quick Pediatric Logistic Organ Dysfunction 2, compared with 85.0% (95% CI, 84.0–86.0%) for Pediatric Risk of Mortality 3 and 81.5% (95% CI, 80.5–82.5%) for Pediatric Index of Mortality 2. Performance of quick Pediatric Logistic Organ Dysfunction 2 was worst in the greater than 12 years age group (area under the receiver operating characteristic curve, 67.8%; 95% CI, 65–70.5) and best in the less than 1 month age group (area under the receiver operating characteristic curve, 78.9%; 95% CI, 75.3–82.4). Conclusions: Quick Pediatric Logistic Organ Dysfunction 2 performed markedly worse in our cohort, compared with the original study, and the high rate of false negatives limits its clinical utility in our population. Further work is needed to develop a robust quick pediatric sepsis diagnostic tool for both research and clinical care. Dr. Görges helped design the study, collect the data, analyze the data, and prepare the article. Dr. Peters helped design the study, analyze the data, and prepare the article. Dr. Murthy helped design the study and prepare the article. Dr. Pi helped analyze the data and prepare the article. Dr. Kissoon helped design the study, collect the data, and prepare the article. Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (https://ift.tt/2gIrZ5Y). Dr. Görges disclosed that he holds grant funding from the Canadian Institutes of Health Research and BC Children’s Hospital Research Institute for unrelated work, and there is a licensing agreement between University of British Columbia and NeuroWave Systems for control technology unrelated to the presented work. The remaining authors have disclosed that they do not have any potential conflicts of interest. For information regarding this article, E-mail: mgorges@bcchr.ca ©2018The Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
from Emergency Medicine via xlomafota13 on Inoreader https://ift.tt/2NlAarP
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Ravulizumab (ravulizumab-cwvz; ULTOMIRIS™), a humanized monoclonal antibody, is a complement C5 inhibitor developed by Alexion Ph...
-
http://bit.ly/2TO0eLw
-
Abstract Chronic low-grade inflammation is now widely accepted as one of the most important contributors to metabolic disorders. Glycoprot...
-
Abstract Objective Long-acting synthetic somatostatin analogues (SSA) are an essential part of the treatment of neuroendocrine neoplasms...
-
Training in teamwork behaviour improves technical resuscitation performance. However, its effect on patient outcome is less clear, partly be...
-
Medicine by Alexandros G. Sfakianakis BioMed Research International BioMed Research InternationalTanshinone IIA Alleviates CCL2-Induced Le...
-
Abstract Chronic venous disease (CVD) is both prevalent and unavoidable in many people as a result of persistent or unalterable risk facto...
-
Abstract Purpose Reports of acute treatment-related dysphagia and toxicities for patients with parotid tumours or cutaneous head and nec...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου